Condition (MeSH)
Duodenogastric Reflux
ClinicalTrials.gov lists 10 trials for Duodenogastric Reflux or a narrower condition beneath it. Zagazig University has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
1 of the 10 trials are tagged with Duodenogastric Reflux itself; the rest are tagged with a narrower condition beneath it.
When did Duodenogastric Reflux trials start? (8)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2022 | 1 |
| 2020 | 2 |
| 2019 | 2 |
| 2018 | 1 |
| 2016 | 1 |
| 2014 | 1 |
| 2007 | 1 |
| 2002 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 10 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Duodenogastric Reflux trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Not applicable | 3 |
| Observational | 6 |
How many Duodenogastric Reflux trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 5 |
| Unknown status | 5 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Duodenogastric Reflux trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Zagazig University | 1 |
Which drugs are being tested for Duodenogastric Reflux? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Omeprazole 20 mg | 1 |
Interventions as named in the registry (1)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| LAR Lanreotide | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Duodenogastric Reflux? (16)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Hyperinsulinemia Promotes Esophageal Cancer Development in a Surgically-Induced Duodeno-Esophageal Reflux Murine Model. | International journal of molecular sciences | 2018 | Yes |
| [Duodenogastric reflux and gastric pathology in the elderly patients]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology | 2010 | Yes |
| Reflux of duodenal contents and cholangitis in patients undergoing self-expanding metal stent placement. | Gastrointestinal endoscopy | 2009 | Yes |
| Effect of Roux-en-Y gastric bypass in obese patients with Barrett's esophagus: attempts to eliminate duodenogastric reflux. | Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery | 2008 | Yes |
| Bile reflux index after therapeutic biliary procedures. | BMC gastroenterology | 2008 | Yes |
Showing 5 of 16 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and rare-disease identity.